Related Experiment Videos
Serotype-specific mortality from invasive Streptococcus pneumoniae disease revisited
Pernille Martens1, Signe Westring Worm, Bettina Lundgren
1Department of Infectious Diseases 144, Hvidovre University Hospital, DK-2650 Hvidovre, Denmark. pernillemartens@yahoo.com
BMC Infectious Diseases
|July 2, 2004
Summary
Streptococcus pneumoniae serotypes significantly impact invasive disease outcomes. Serotype 3 increased mortality risk, while serotype 1 decreased it, highlighting serotype virulence in vaccine development.
Area of Science:
- Infectious Diseases
- Microbiology
- Epidemiology
Background:
- Invasive Streptococcus pneumoniae infections cause substantial illness and death.
- Pneumococcal capsular serotypes play a role in disease development and severity.
Purpose of the Study:
- To investigate the association between specific pneumococcal capsular serotypes and mortality risk in invasive pneumococcal disease.
- To identify independent predictors of mortality in adults with invasive pneumococcal disease.
Main Methods:
- Retrospective analysis of 464 adult invasive pneumococcal disease cases (1990-2001).
- Multivariate Cox proportional hazard modeling was employed to assess risk factors.
Main Results:
- Infection with serotype 3 was linked to a 2.54-fold increased risk of death (RR 2.54, 95% CI: 1.22-5.27).
- Infection with serotype 1 was associated with a decreased risk of death (RR 0.23, 95% CI: 0.06-0.97).
- Older age, leucopenia, and hypothermia were independent predictors of mortality.
Conclusions:
- Pneumococcal capsular serotypes independently influence invasive disease outcomes.
- Current polysaccharide vaccines have limitations, necessitating new vaccine development.
- Pneumococcal serotype virulence should be a key consideration for novel vaccine design.